Project Number ADDF-18 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2020 View Full Project Details for Validation of blood based biomarkers for the detection of brain amyloid accumulation before clinical onset of dementia Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers b. Blood-based Biomarkers Researcher and Organization Principal Investigator Anderson, Leyla Principal Investigator Anderson, Leyla Awardee Organization NeuroVision Imaging, Inc. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Neuroimaging and CSF Biomarkers Program FY Overall Cost $539,259 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management
